Arvinas, Inc.
NASDAQ:ARVNBiotechnology
-$0.10 today
- Market cap
- $443.01M
- Beta
- 1.75
- P/E (TTM)
- -2.2
- EPS (TTM)
- -$3.46
Volume 1.09M
Average 0.89M
ARVN Total Current Assets
All assets expected to be converted to cash or used up within one year.
Arvinas, Inc.NASDAQ: ARVN
Total Current Assets · Q1 FY2026 · quarter ended Mar 2026
Total current assets falls 35.6% from a year ago
Total current assets stood at $630.7M at the end of Q1 FY2026, down 35.6% from a year earlier and down 10.0% from the prior quarter. Over 3 fiscal years it compounded at -17.3% a year.
Context
- Total current assets amounted to 97.4% of total assets at the end of Q1 FY2026, down 0.5 pp from a year earlier.
- Total current assets increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether total current assets keeps falling in the next quarterly balance sheet after a -35.6% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Current Assets history
USD · from the balance sheet
- Latest · FY2025
- 700.7M USD
- Year-over-year change
- -34.3%
- 4-year CAGR
- -18.0%
| Period | Period end | Total Current Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 700.7M | -34.3% |
| FY2024 | 2024-12-31 | 1.07B | -16.6% |
| FY2023 | 2023-12-31 | 1.28B | +3.2% |
| FY2022 | 2022-12-31 | 1.24B | -20.1% |
| FY2021 | 2021-12-31 | 1.55B | — |
Total Current Assets vs competitors
How ARVN compares with its peers on the latest reported figures
- ARVN's Mar 2026 total current assets of $630.7M is the 4th highest of the 6 companies compared; the peer median is $677.55M.
- Its year-over-year change of -35.6% is the lowest of 6, against a peer median of +5.5%.
- Total current assets amounts to 97.4% of total assets for ARVN, versus a peer median of 84.6%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Aug 2026 | $1.1B | +150.5% | +24.0% | 92.3% | |
| Jun 2026 | $737.27M | +1.2% | +27.6% | 44.8% | |
| Mar 2026 | $677.55M | +103.9% | +12.5% | 92.0% | |
| Mar 2026 | $630.7M | -35.6% | -17.3% | 97.4% | |
| Mar 2026 | $245.37M | +5.5% | -3.5% | 74.6% | |
| Mar 2026 | $188.06M | -16.6% | -22.6% | 84.6% | |
| Peer median (excluding ARVN) | $677.55M | +5.5% | +12.5% | 84.6% | |
Competitors are the stored peer set for ARVN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 108.3M | 81.3M | 311.7M | 100.5M | 142.9M |
| Short-term Investments | 1.39B | 1.12B | 949.3M | 938.9M | 542.5M |
| Net Receivables | 25.7M | 8M | 7.2M | 13.7M | 6.4M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 4.5M | 26.9M | 12M | 14.2M | 8.9M |
| Total Current Assets | 1.55B | 1.24B | 1.28B | 1.07B | 700.7M |
| Property, Plant & Equipment (Net) | 16.6M | 17.8M | 14M | 16M | 13.4M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 12.5M | 10.8M | 10.4M | 8.1M | 3.8M |
| Total Non-current Assets | 29.1M | 28.6M | 24.4M | 24.1M | 17.2M |
| Total Assets | 1.58B | 1.27B | 1.3B | 1.09B | 717.9M |
| Account Payables | 31.3M | 5.7M | 17.8M | 13.4M | 24.4M |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Tax Payables | 0 | 10.3M | 700K | 3.2M | 0 |
| Deferred Revenue | 206.2M | 218.6M | 163M | 156.2M | 71.3M |
| Other Current Liabilities | 12.4M | 18.7M | 48M | 22.4M | 17.5M |
| Total Current Liabilities | 261.7M | 295.1M | 257.1M | 229.8M | 142.5M |
| Long-term Debt | 1M | 1M | 800K | 600K | 400K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 534.3M | 405.1M | 386.2M | 292M | 134.3M |
| Other Non-current Liabilities | 0 | 0 | 0 | 0 | 100K |
| Total Non-current Liabilities | 538.2M | 408.8M | 387.5M | 299.9M | 141.6M |
| Total Liabilities | 799.9M | 703.9M | 644.6M | 529.7M | 284.1M |
| Common Stock | 0 | 100K | 100K | 100K | 0 |
| Retained Earnings | (682.9M) | (965.4M) | (1.33B) | (1.53B) | (1.61B) |
| Accumulated OCI | (4.6M) | (19.2M) | (3.1M) | 1M | 1.2M |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 781.7M | 564.9M | 660M | 561.7M | 433.8M |
| Total Debt | 5M | 5.5M | 3.2M | 9.7M | 8.9M |
| Net Debt | (103.3M) | (75.8M) | (308.5M) | (90.8M) | (134M) |
Arvinas, Inc.
NASDAQ:ARVN
Intrinsic Alpha fair value
Locked
Current Price
$6.77
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.